EUVIMEDSkopri EUVIMED
Crossref

Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory

Linas Griguola iD, Kestutis Cerniauskas, Laura Malinauskiene iD, Kotryna Linauskiene, Justina Rudyte, Anzelika Chomiciene

Contact Dermatitis · 2025

DOI: 10.1111/cod.14715 ↗

At a glance

Journal article in Contact Dermatitis, 2025. Written by Linas Griguola and 5 co-authors. Institution: Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania. Major MEDLINE topics: Dermatitis, Allergic Contact, Patch Tests, Dermatitis, Occupational, Dicyclohexylcarbodiimide. Cited 4 times so far (Crossref); 25 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Dicyclohexylcarbodiimide (DCC) is known to cause occupational allergic contact dermatitis in biotechnology laboratory workers.

Objectives

This study aimed to assess the prevalence of DCC sensitization among workers of one biosynthesis laboratory and to determine the optimal DCC concentration for patch testing. Materials and methods 23 laboratory workers frequently exposed to DCC of whom 21 suffered from dermatitis and 11 controls were enrolled into the study. All participants underwent skin patch testing with different concentrations of DCC and other substances used in the work environment. Statistical analysis was conducted to compare results between active and control groups.

Results

Of the 23 workers tested, 56.5% showed positive reactions to DCC. All of them had dermatitis. Morpholine also elicited positive reactions in 26.1% of workers who were all sensitized to DCC. Dimethylformamide and chloroform yielded negative results.

Conclusion

Dicyclohexylcarbodiimide was a major cause of contact dermatitis in the active group indicating an outbreak of contact allergy to DCC in the company necessitating preventive measures. Both DCC 0.1% ac. and DCC 0.05% pet. should both be used for patch testing.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactPatch TestsDermatitis, OccupationalDicyclohexylcarbodiimideHumansAdultMaleFemaleBiotechnologyMiddle AgedDisease OutbreaksLaboratoriesCase-Control StudiesYoung Adult

Author keywords

allergic contact dermatitisoccupationalpatch test

Substances

Dicyclohexylcarbodiimide

Authors and institutions

  • Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania.
  • Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

ORCID profiles: Linas Griguola, Laura Malinauskiene

Cite

APA

Griguola, L., Cerniauskas, K., Malinauskiene, L., Linauskiene, K., Rudyte, J., & Chomiciene, A. (2025). Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. https://doi.org/10.1111/cod.14715

Vancouver

Griguola L, Cerniauskas K, Malinauskiene L, Linauskiene K, Rudyte J, Chomiciene A. Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. 2025. doi:10.1111/cod.14715

BibTeX
@article{Griguola2025,
  author = {Griguola, Linas and Cerniauskas, Kestutis and Malinauskiene, Laura and Linauskiene, Kotryna and Rudyte, Justina and Chomiciene, Anzelika},
  title = {Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory},
  journal = {Contact Dermatitis},
  year = {2025},
  doi = {10.1111/cod.14715}
}
Start for free →